Edmond de Rothschild Holding’s SOPHiA GENETICS SOPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.15M Sell
200,004
-3,330
-2% -$16.9K 0.02% 288
2026
Q1
$1.01M Hold
203,334
0.01% 288
2025
Q4
$950K Hold
203,334
0.01% 297
2025
Q3
$968K Hold
203,334
0.02% 294
2025
Q2
$630K Hold
203,334
0.01% 316
2025
Q1
$675K Hold
203,334
0.01% 300
2024
Q4
$634K Hold
203,334
0.01% 314
2024
Q3
$739K Hold
203,334
0.01% 292
2024
Q2
$931K Hold
203,334
0.02% 291
2024
Q1
$1M Buy
203,334
+9,700
+5% +$46.8K 0.02% 310
2023
Q4
$912K Hold
193,634
0.02% 311
2023
Q3
$494K Hold
193,634
0.01% 364
2023
Q2
$867K Hold
193,634
0.02% 337
2023
Q1
$962K Buy
193,634
+12,300
+7% +$39.8K 0.02% 328
2022
Q4
$374K Hold
181,334
0.01% 401
2022
Q3
$477K Buy
181,334
+17,579
+11% +$61.6K 0.01% 370
2022
Q2
$593K Buy
+163,755
New +$831K 0.01% 376

Other funds holding SOPH

Edmond de Rothschild Holding's SOPH Position: Q2 2026 in Review

Edmond de Rothschild Holding reduced its SOPHiA GENETICS (SOPH) stake by 1.6% in Q2 2026, selling an estimated $16.9K and leaving 200,004 shares worth $1.15M. The position accounts for 0.02% of the portfolio, ranked #288.

Edmond de Rothschild Holding first reported a position in SOPH in Q2 2022 and has held it in 17 quarters since. 72 funds tracked by Wall St. Rank hold SOPH as of Q2 2026.

  • Edmond de Rothschild Holding held 200,004 shares of SOPHiA GENETICS worth $1.15M as of Q2 2026.
  • Edmond de Rothschild Holding sold 3,330 SOPHiA GENETICS shares in Q2 2026, an estimated $16.9K.
  • SOPHiA GENETICS made up 0.02% of Edmond de Rothschild Holding's portfolio in Q2 2026, its #288 holding.
  • Edmond de Rothschild Holding first reported a position in SOPHiA GENETICS in Q2 2022 and has held it in 17 quarters since.
  • 72 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2026.

Based on Edmond de Rothschild Holding's 13F filing for Q2 2026, filed 10 Aug 2026.